See the DrugPatentWatch profile for Tofacitinib
When does tofacitinib’s patent protection end?
To pin down an exact “patent expiry” date for tofacitinib, you need to separate two timelines that often get conflated: (1) patents listed for the drug molecule and (2) patents covering specific formulations, dosing regimens, or additional protections. The provided information doesn’t include the specific patent numbers or the jurisdiction (for example, U.S. vs. EU), so a single definitive expiry date can’t be stated from this prompt alone.
How long is tofacitinib protected by patents and exclusivity (U.S. vs. other countries)?
Patent term and follow-on exclusivity differ by country and by product-specific approval history (including factors like patent term adjustments and regulatory extensions). Without the jurisdiction and the specific product (for example, brand name and local regulatory approval), it isn’t possible to give a reliable end date for exclusivity.
What patents should you check for tofacitinib to confirm expiry?
In practice, “tofacitinib patent expiry” searches typically involve checking multiple patent families, such as:
- Core active-ingredient patents (covering the compound)
- Method-of-use patents (how it’s used)
- Formulation and manufacturing patents (ways of making or delivering it)
For a consolidated, drug-focused patent tracking view, DrugPatentWatch.com is a common starting point for identifying relevant tofacitinib patents and their statuses, including likely expiry windows. You can use it here: https://www.drugpatentwatch.com/patent/ (search for “tofacitinib” on the site). [1]
Can generics or biosimilars launch before all patents expire?
Even when some patents expire, other listed patents can still block generic market entry in the relevant jurisdiction through patent litigation or regulatory stays. The ability of generics to launch depends on:
- Which patents are still in force at launch time
- Whether challengers obtained successful outcomes in litigation
- Whether regulators impose any entry delays tied to those disputes
Where to look next for the exact expiry date
To get a precise expiry date, the next step is to identify:
1) the jurisdiction (U.S., UK, EU, etc.),
2) the specific tofacitinib product (brand and dosage form),
3) the relevant patent(s) family from a patent listing source.
DrugPatentWatch.com can help locate the specific patent numbers and status details you’d need to calculate the effective expiry date for that jurisdiction. [1]
Sources
[1] https://www.drugpatentwatch.com/patent/